What if you'd held EDSA?
A $1,000 investment in Edesa Biotech, Inc. (EDSA) at the month-end close of 2010-06 would be worth $9.31 at the close of 2026-08 — -99.1% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $7,478.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2010
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2010 | $1,000 | — |
| 2011 | $273 | -72.7% |
| 2012 | $203 | -25.6% |
| 2013 | $1,231 | +506.9% |
| 2014 | $811 | -34.1% |
| 2015 | $454 | -44.1% |
| 2016 | $142 | -68.7% |
| 2017 | $56.64 | -60.1% |
| 2018 | $9.09 | -84.0% |
| 2019 | $6.83 | -24.9% |
| 2020 | $7.08 | +3.7% |
| 2021 | $9.37 | +32.5% |
| 2022 | $3.60 | -61.6% |
| 2023 | $1.09 | -69.8% |
| 2024 | $0.40 | -63.2% |
| 2025 | $0.34 | -15.5% |
| 2026 | $1.37 | +304.9% |
Best and worst month-end to buy
The best single month-end close to have bought EDSA was 2026-01 ($1.17): $1,000 then is $4,915 today. The worst was 2013-10 ($5,439): $1,000 then is $1.06.
FAQ
What would $1,000 in EDSA be worth today?
A $1,000 investment in Edesa Biotech, Inc. (EDSA) at the start of 2010 would be worth about $9.31 today, a total return of -99.1%. Dividends are reinvested in these figures.
What were the best and worst years for EDSA?
Edesa Biotech, Inc. (EDSA)'s strongest calendar year since 2010 was 2013, a +506.9% return — $1,000 held through that year became about $6,069 by year-end. Its weakest year was 2018, at -84.0%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in EDSA have grown?
Investing $100 at the end of every month since 2010-06 would have grown to about $9,149 on $19,500 invested.
Did EDSA beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $7,478. EDSA trailed the S&P 500 by +99.9% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Edesa Biotech, Inc. (EDSA) historical total-return data from 2010-06 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.